Scotland · NHS Scotland MSAN
Isosorbide mononitrate 60mg modified-release tablets and capsules - Update
MSAN(2024)57 · Level 2 · issued 04 Oct 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Chemydur® 60XL tablets are out of stock until mid-October 2024. | Out of stock | mid-October 2024 |
| 2. Monomax® XL 60mg tablets are out of stock until early October 2024. | Out of stock | early October 2024 |
| 3. Monomil® XL 60mg tablets are in limited supply until late December 2024. | Limited supply | late December 2024 |
| 4. Nyzamac® SR 60mg capsules are out of stock until late October 2024. | Out of stock | late October 2024 |
| 5. Isotard® 60XL, Medomon® XL, Relosorb® XL and Tardisc® XL 60mg tablets remain available | Available | — |
| 6. Other brands of isosorbide mononitrate 60mg modified-release tablets are available, however | Available | — |
| cannot support the increase in demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.